Consumer Healthcare Products Association competitors

Greg Roderick is a CEO & President at Frontier Management, LLC and is based in Portland, Oregon. He has worked as Regional Manager at Holiday Retirement, Vice President of Operations at Regent Assisted Living Inc, and CFO at ST LOUIS CHILDREN'S HOSPITAL. Greg works or has worked as Executive Board Member at American Seniors Housing Association. He studied at University of Oregon between 1986 and 1988.

Christine Zambricki is a Chief Executive Officer at AMERICA S BLOOD CENTERS and is based in Bloomfield Hills, Michigan. She has worked as Deputy Executive Director/Senior Director Federal Affairs Strategies at American Association of Nurse Anesthetists, Administrative Director at Mercy Hospitals and Health Systems of Detroit, and Chief Operating Officer and Chief Nursing Officer at Henry Ford Health System. Christine studied at Virginia Commonwealth University, Michigan State University between 1972 and 1976, and Wayne State University between 1976 and 1978.

Mike S. Perry was appointed as Chief Executive Officer (CEO) of AVITA Medical in June 2017, after serving on the Board since February 2013. He brings extensive experience across the global pharmaceutical value chain for healthcare products spanning diverse therapeutic areas, including substantial expertise in cell therapies and cell-based gene therapies. In his career, he has been materially involved in the successful development and commercial launch of over 30 prescription products, 14 of which achieved blockbuster status. Prior to joining AVITA, Dr. Perry’s leadership positions included Chief Scientific Officer of Novartis’ Cell and Gene Therapy Unit from 2014-2017; Vice President and Global Head of Stem Cell Therapy for Novartis Pharmaceuticals Corp. from 2012-2014. With additional positions held as Global Head of R&D at Baxter Healthcare; President and CEO of Cell & Gene Therapy at Novartis affiliates Systemix Inc. and Genetic Therapy, Inc.; Vice President of Regulatory Affairs at Sandoz Pharmaceuticals Corporation; Director of Regulatory Affairs at Schering-Plough Corporation; and Venture Partner with Bay City Capital, LLC, Dr. Perry brings successful global management, guidance and forward direction to AVITA. Since 2011, has served as a Director with Arrowhead Pharmaceutical expanding his reach in influential medical growth.